NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Entact Bio

Entact Bio

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://entactbio.com/

Last Round

Seed Round

Jun 3, 2026

Total Funding Raised

$121.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Entact Bio is a biotechnology company that develops small-molecule drugs called ENTACs to enhance the function of beneficial proteins through natural cellular mechanisms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

enhancement-targeting chimerasENTACsprotein enhancementsmall-molecule drugsdrug discovery platformdeubiquitinase enzymesDUBsprotein stabilizationDUBtacsDUB recruitingproteostasis modulatorsundruggable targetschimeric moleculesprecision medicinebiotech partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Entact Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Entact Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 3, 2026
Series A ExtensionJan 17, 2024
Series ADec 6, 2022
SeedOct 1, 2019

Key People

Founding team and executive leadership

Victoria Richon

Chief Executive Officer

Executive Team

Entact Bio Investors

Notable investors and investment history

InvestorRounds
Surveyor CapitalSeries A
Janus Henderson GroupSeries A
4Bio CapitalSeries A, Seed
Logos CapitalSeries A
AbingworthSeries A
Arkin HoldingsSeries A
CitadelSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $10M raised in Seed Round.

  • Dec 6, 2022

    $81M round led by Qiming

Entact Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Entact Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Entact Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range21
Year Founded2019
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.